Brinks
BCO · NYSE
About BCO
- Employees
- 63,600
- Headquarters
- Richmond, Virginia
- Listed
- Jan 3, 1996
- Sector
- Industrials
- Industry
- Commercial Services & Supplies
- Website
- investors.brinks.com
BCO key statistics
- Market cap
- 4.42B
- Price-earnings ratio
- 23.94
- Dividend yield
- 0.97%
- Average volume
- 421.23K
- Volume
- 809.02K
- Open price
- $104.08
- High today
- $107.42
- Low today
- $102.39
- 52 Week high
- $136.37
- 52 Week low
- $91.05
Brinks (BCO) at a glance
As of Oct 20, 2026, Brinks (BCO) shares are priced at $107.24, giving the company a market cap of 4.42B, a price-to-earnings ratio of 23.93 and a dividend yield of 0.97%.
Today the stock has traded between $102.39 and $107.42. The current price is 4.7% above the day's low and 0.2% below its high.
Volume so far is 809.02K shares, above the average of 421.23K shares a day.
Over the past year Brinks has ranged from $91.05 to $136.37, and now sits 36% of the way up that range.
Brinks met or beat analyst EPS estimates in 6 of the last 8 quarters. In Q2 FY26 it reported $2.13 per share against an estimate of $2.06.
The average analyst price target is $149.26, 39.2% above the current price, from 2 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy100.0%
- Hold0.0%
- Sell0.0%
- Low
- $139.38
- Now
- $107.24
- High
- $171.15
BCO earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 6 of the last 8 quarters, by 15.0% on average.
- Q3 FY24: reported $1.51 per share against an estimate of $1.80
- Q4 FY24: reported $2.12 per share against an estimate of $1.91
- Q1 FY25: reported $1.62 per share against an estimate of $1.19
- Q2 FY25: reported $1.79 per share against an estimate of $1.46
- Q3 FY25: reported $2.08 per share against an estimate of $2.10
- Q4 FY25: reported $2.54 per share against an estimate of $2.50
- Q1 FY26: reported $1.80 per share against an estimate of $1.58
- Q2 FY26: reported $2.13 per share against an estimate of $2.06
BCO news
- Press releasePRNewswire
Are BCO, SEM, NATL Obtaining Fair Deals for their Shareholders?
- Press releaseBusiness Wire
NCR Atleos Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of NCR Atleos Corporation - NATL
- Press releasePRNewswire
Are STEL, BCO, SEM, NATL Obtaining Fair Deals for their Shareholders?
- Press releasePRNewswire
Are BCO, NATL, COUR Obtaining Fair Deals for their Shareholders?
- Press releasePRNewswire
SHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--UDMY, COUR, BCO, and NATL
- Press releasePRNewswire
SHAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--THR, BCO, NATL, and KORE
- Press releasePRNewswire
Are PEN, STKL, BCO, LNKB Obtaining Fair Deals for their Shareholders?
Similar companies
Companies in the same industry as Brinks
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.